News
Keep up to date with our latest news
Vitaccess and Myasthenia Gravis Foundation of America form strategic partnership to advance generation of real-world evidence in MG
Boston, MA, USA and Oxford, UK – 12 February 2026. Vitaccess, a leader in generating science-driven real-world evidence, has entered into an exclusive partnership with the Myasthenia Gravis Foundation of America (MGFA), making the MGFA the official collaborator for...
ISOQOL 30th Annual Conference take-aways
The International Society for Quality of Life Research (ISOQOL) 30th Annual Conference took place last month in Calgary, providing the opportunity for researchers, healthcare professionals, industry representatives, and patient research partners to explore the use of...
ISPOR EU 2023
ISPOR Europe is on the horizon and we’ll be exhibiting four posters at stand C2-027, and Mark Larkin, CEO, will be speaking at an educational symposium. This year’s conference will focus on the role of health economics and outcomes research science in shaping policy –...
30 Years of ISOQOL: Quality of Life – making it relevant
The 30th annual ISOQOL conference is taking place in Calgary, Canada, on 18th - 21st October. This year, the theme will be “Quality of Life – making it relevant”, with a focus on identifying the many barriers that limit the use of patient-reported outcomes in...
MyRealWorld MG study announcement
The MyRealWorld MG study, a longitudinal digital observational study exploring the impact of myasthenia gravis (MG) from the patient perspective, has been run by Vitaccess on behalf of argenx since December 2019. Since then, over 2,400 adults with MG residing across...
American Health Research study launch
We are delighted to announce that this month, American Health Research, in collaboration with Vitaccess, have launched the investigator-initiated AHR CB study. The study is designed to help researchers learn how Mucinex® could be used as a long-term treatment to...
Join our ISPOR short course
Join Dr Mark Larkin, Dr Catherine Bottomley, and Dr Casey Quinn for the virtual ISPOR short course on Digital Real-World Evidence Generation Approaches in Rare Diseases and Oncology.The course is designed to provide a good understanding of how to plan and undertake...
ISPOR Europe 2022
This year’s conference theme is “Collaborating across borders: building and using evidence to enable access” – a perfect opportunity to discuss our capabilities with you and explore how we can help you launch and run real-world studies. Get in touch to book a meeting...
ISOQOL Annual Conference 2022 – attend our workshop
The 29th annual ISOQOL conference is taking place in Prague, October 19–22. This year, the theme will be “Redefining boundaries – breaking new ground in patient-centered outcomes research”. We'll be there, will you?We will be hosting a workshop on “Balancing...
MyRealWorld™ MG reaches over 2,000 participants!
As of late April, the MyRealWorld™ MG (MRW MG) study has reached over 2,000 participants! Study participants are based in Italy, the USA, Spain, Belgium, Canada, Japan, Germany, the UK, France, and Denmark. We would like to sincerely thank all participants, patient...
It’s ISPOR 2022 – let’s talk!
During ISPOR 2022, speak to the Vitaccess team about your real-world evidence projects. We’re here to help. We are regulars at the annual ISPOR conference, with a number of posters and workshops presented in the past. We’re not attending the event in May but hope to...
MyRealWorld™ MG: Study launch in Denmark
On March 23, 2022, the MyRealWorld™ MG (MRW MG) study expanded to include Denmark in its list of study countries. This means that the digital real-world evidence study, which has been ongoing since December 2019, now operates across nine countries: the US, Canada,...
Envision Pharma Group and Vitaccess create a global partnership
Envision Pharma Group and Vitaccess create a global partnership to power evidence generation for the biopharmaceutical industry Move combines Envision’s global leadership position in medical affairs communications with Vitaccess’ award-winning capabilities in...
Vitaccess at Virtual ISPOR Europe 2021
ISPOR Europe 2021 is just around the corner and the Vitaccess team is looking forward to sharing insights with you during the event as well as our poster presentations. We will be part of the podium session “Two years of COVID-19: what has been the global impact on...
Early access innovator, RareiTi, and innovative research organization, Vitaccess, partner on real-world data services in rare disease
RareiTi Inc., a data-driven early access and clinical patient services company, and Vitaccess Ltd, a multi-award-winning digital real-world evidence (RWE) research and strategy specialist, announce a collaboration offering unique services in RWE to support...
Vitaccess receives ISO 9001 and ISO 27001 certifications
In record time, Vitaccess has successfully achieved UKAS-accredited certification, through Approachable Certification (our audit body), to two ISO standards. With a process that started only 6 months earlier, the Vitaccess team came together to achieve this huge...
Vitaccess rebrand celebrates 4 years of ‘real progress’
Award-winning digital health leader, Vitaccess, is looking to the future with a bold, high-res rebrand. The striking new visual identity reflects Vitaccess’ meteoric rise as a global next-generation real-world evidence and strategy specialist.Vitaccess, founded by Dr...
Vitaccess wins a Queen’s Award for Enterprise
Digital healthcare scale-up Vitaccess has been honored with a Queen's Award for Enterprise in the Innovation category.Now in its 55th year, the Queen’s Awards for Enterprise are the most prestigious business awards in the UK, recognizing the success of exciting and...
